Locate Bio Ltd

Locate Bio Ltd is a UK-based company focused on regenerative medicine and MedTech, specializing in next-generation orthobiologics.

Their innovative products are designed to promote the healing and regeneration of musculoskeletal tissues, including bones, muscles, tendons, and ligaments. The company utilizes programmed drug release and instructive tissue scaffoldsTM to create effective solutions for surgeons, aiming to enhance the quality of life for the 1.7 billion people worldwide affected by musculoskeletal conditions. Founded in 2001 as RegenTec Limited and later rebranded, Locate Bio is headquartered in Nottingham, UK. The company operates in the fields of medical equipment manufacturing, regenerative medicine, and drug discovery. Their product pipeline includes advanced solutions for bone regeneration, infection control, and cartilage repair, with notable products like LDGraft, which is currently in clinical trials and has received FDA Breakthrough Device designation. Locate Bio also collaborates with pharmaceutical and biopharmaceutical companies, providing advanced delivery systems and regenerative matrices to improve patient outcomes.